Multiple Sclerosis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- A neurologist has confirmed a diagnosis of Multiple Sclerosis (MS) using a standard set of diagnostic guidelines called the McDonald criteria.
- The person has the relapsing-remitting type of MS (known as RRMS), where symptoms come and go in episodes.
- The person has been living with an MS diagnosis for at least one year.
- The person is between 18 and 65 years old.
- The person has a disability score (called an EDSS score) between 0 and 5, which reflects mild to moderate levels of disability.
- The person has not used steroid medications, or stopped using them at least 3 months before joining the trial.
- The person has not had an MS relapse (a flare-up of symptoms) in the past 3 months.
- The person has not previously used acupressure or other complementary therapies.
- The person has enough language ability to understand the study and complete any questionnaires or assessments involved.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- The person has open wounds or physical deformities at the site where the treatment would be applied.
- The person has another brain or nerve-related condition, such as Parkinson's disease or Alzheimer's disease, that could affect the study results.
- The person is pregnant or breastfeeding, as hormonal changes during these times may affect results.
- The person has a serious condition affecting the heart, lungs, liver, kidneys, or a severe psychiatric illness.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Seyma Demir Erbas, PhD, Abant Izzet Baysal University
Phone: +90(546)4715674
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Beta-Endorphin levels; Hypocretin levels; Cognition
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.